CONNECT BIOPHARMA HLDGS LTD's ticker is CNTB and the CUSIP is 207523101. A total of 17 filers reported holding CONNECT BIOPHARMA HLDGS LTD in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,725,631 | -27.5% | 6,991,003 | 0.0% | 0.11% | -24.2% |
| Q2 2023 | $7,899,833 | +13.0% | 6,991,003 | 0.0% | 0.15% | -5.7% |
| Q1 2023 | $6,990,304 | +15.2% | 6,991,003 | 0.0% | 0.16% | +28.5% |
| Q4 2022 | $6,066,792 | -32.7% | 6,991,003 | 0.0% | 0.12% | -35.9% |
| Q3 2022 | $9,018,000 | +48.3% | 6,991,003 | 0.0% | 0.19% | +18.5% |
| Q2 2022 | $6,082,000 | -71.2% | 6,991,003 | 0.0% | 0.16% | -64.9% |
| Q1 2022 | $21,113,000 | -41.4% | 6,991,003 | 0.0% | 0.46% | -27.4% |
| Q4 2021 | $36,004,000 | -78.7% | 6,991,003 | 0.0% | 0.64% | -72.9% |
| Q3 2021 | $169,392,000 | +24.1% | 6,991,003 | 0.0% | 2.35% | +7.1% |
| Q2 2021 | $136,534,000 | +146.7% | 6,991,003 | +133.7% | 2.19% | +162.7% |
| Q1 2021 | $55,337,000 | – | 2,991,208 | – | 0.83% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,991,003 | $5,725,631 | 0.11% |
| Kynam Capital Management, LP | 535,005 | $434,003 | 0.07% |
| UBS OCONNOR LLC | 603,900 | $468,626 | 0.01% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 650,000 | $532,350 | 0.00% |
| Qube Research & Technologies Ltd | 46 | $36 | 0.00% |
| JPMORGAN CHASE & CO | 23,532 | $18,249 | 0.00% |
| Renaissance Technologies | 97,000 | $79 | 0.00% |
| ROYAL BANK OF CANADA | 255 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 16,520 | $12,802 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 17,219 | $14,102 | 0.00% |